TEXT OF STORY
Bill Radke: The seed and herbicide company Monsanto reports earnings this morning before the bell. Analysts expect to hear profits have fallen — withered, one may say — from a year ago. From KWMU in St. Louis, Adam Allington reports.
Adam Allington: In recent years, profitability at Monsanto has been driven by its hot-selling herbicide, Roundup. Those sales are decreasing as cheap, Roundup-like alternatives enter the market.
Laurence Alexander: Those competitors are now flooding the business, pricing is coming down, and investors are forced to pay attention to what is the ugly cousin, so to speak.
Laurence Alexander is an analyst for Jefferies and Company. He says the trick Monsanto needs to pull off is keep that ugly cousin off the stage and introduce investors to some of their sexier next generation seed products.
Alexander: That’s the part of the business investors want to hear about, it’s the side of the business people want to pay for.
Alexander says sales of Roundup could fall by half over the next several years. However, Monsanto is hoping that investors stay on board while the company transitions to new products.
I’m Adam Allington For Marketplace.
News and information you need, from a source you trust.
In a world where it’s easier to find disinformation than real information, trustworthy journalism is critical to our democracy and our everyday lives. And you rely on Marketplace to be that objective, credible source, each and every day.
This vital work isn’t possible without you. Marketplace is sustained by our community of Investors—listeners, readers, and donors like you who believe that a free press is essential – and worth supporting.